enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q2 2025
Institutional positions in enGene Therapeutics Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +5 vs. Q1 2025
- Shares held
- 40.4M
- −530.9K (−1.3%) vs. Q1 2025
- Total value
- $147.1M
- −$36.3M (−19.8%) vs. Q1 2025
- New holders
- 8
- 4 more added
- Sold out
- 3
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 30 | $109 | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 380 | $1.00K | 0.00% | +380 | New |
| Raymond James Financial Inc | 2,068 | $7.53K | 0.00% | +2,068 | New |
| MAI Capital Management | 2,925 | $10.6K | 0.00% | −75,142−96.3% | Reduced |
| Wells Fargo & Company | 3,199 | $11.6K | 0.00% | +1,278+66.5% | Added |
| Wolverine Asset Management LLC | 6,361 | $23.2K | 0.00% | +6,361 | New |
| Royal Bank of Canada | 7,915 | $29.0K | 0.00% | 00.0% | Unchanged |
| Paloma Partners Management Co | 10,319 | $37.6K | 0.01% | +10,319 | New |
| Renaissance Technologies LLC | 11,400 | $41.5K | 0.00% | +11,400 | New |
| Millennium Management LLC | 13,030 | $47.4K | 0.00% | +13,030 | New |
| Toronto Dominion Bank | 14,537 | $52.9K | 0.00% | 00.0% | Unchanged |
| Pale Fire Capital SE | 17,254 | $62.8K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 23,043 | $83.9K | 0.00% | +23,043 | New |
| ADAR1 Capital Management, LLC | 27,787 | $101.1K | 0.02% | +3,988+16.8% | Added |
| Geode Capital Management, LLC | 29,018 | $105.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 33,026 | $120.2K | 0.00% | −816−2.4% | Reduced |
| Affinity Asset Advisors, LLC | 77,000 | $280.3K | 0.04% | +77,000 | New |
| Schonfeld Strategic Advisors LLC | 174,570 | $635.4K | 0.00% | +40,486+30.2% | Added |
| Marshall Wace, LLP | 343,928 | $1.25M | 0.00% | −1,469−0.4% | Reduced |
| Morgan Stanley | 352,768 | $1.28M | 0.00% | −83,796−19.2% | Reduced |
| Vestal Point Capital, LP | 370,000 | $1.35M | 0.07% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 504,409 | $1.84M | 0.48% | −23,956−4.5% | Reduced |
| Omega Fund Management, LLC | 526,357 | $1.92M | 1.24% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 677,977 | $2.47M | 0.06% | −213,639−24.0% | Reduced |
| Sr One Capital Management, LP | 747,750 | $2.72M | 0.59% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 899,086 | $3.27M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $3.64M | 0.01% | −571,642−36.4% | Reduced |
| Franklin Resources Inc | 1,038,000 | $3.78M | 0.00% | −136,866−11.6% | Reduced |
| Point72 Asset Management, L.P. | 1,208,299 | $4.40M | 0.01% | −32,889−2.6% | Reduced |
| Bank of America Corp | 2,005,708 | $7.30M | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,323,595 | $8.46M | 0.63% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 3,728,106 | $13.6M | 4.38% | +448,728+13.7% | Added |
| Deep Track Capital, LP | 4,557,575 | $16.6M | 0.53% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 4,994,090 | $18.2M | 1.96% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,046,414 | $18.4M | 1.38% | 00.0% | Unchanged |
| FCPM III Services B.V. | 9,632,561 | $35.1M | 9.50% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,832−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −11,700−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |